Cite
Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
MLA
Peter B. McGarvey, et al. “Distinct Lymphocyte Antigens 6 (Ly6) Family Members Ly6D, Ly6E, Ly6K and Ly6H Drive Tumorigenesis and Clinical Outcome.” Oncotarget, vol. 7, no. 10, Feb. 2016, pp. 11165–93. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e0d88b65f4353e254caa948e46b803db&authtype=sso&custid=ns315887.
APA
Peter B. McGarvey, Linlin Luo, Rakesh Kumar, Subha Madhavan, Yuriy Gusev, & Geeta Upadhyay. (2016). Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome. Oncotarget, 7(10), 11165–11193.
Chicago
Peter B. McGarvey, Linlin Luo, Rakesh Kumar, Subha Madhavan, Yuriy Gusev, and Geeta Upadhyay. 2016. “Distinct Lymphocyte Antigens 6 (Ly6) Family Members Ly6D, Ly6E, Ly6K and Ly6H Drive Tumorigenesis and Clinical Outcome.” Oncotarget 7 (10): 11165–93. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e0d88b65f4353e254caa948e46b803db&authtype=sso&custid=ns315887.